Literature DB >> 11163148

Angiogenesis: the role of the microenvironment in flipping the switch.

F J Giordano1, R S Johnson.   

Abstract

The initiating factors in angiogenesis during development and disease are often microenvironmental changes, which induce signaling to the vasculature from affected tissues. Among these, lowered oxygen pressure, hypoxia, is one of the most potent inducers/initiators of an angiogenic response. Significant evidence indicates that hypoxia acts as a morphogen during vascularization - inducing and shaping the recruitment and formation of new vascular beds through critical transcriptional control pathways. Recent advances indicate that extensive interactions occur between developing blood vessels, the tissues that they vascularize, and the interstitial environment to control and shape the establishment of new capillary beds. Identification of the processes that control the hypoxic response intracellularly has allowed an increasingly sophisticated understanding of angiogenesis as a process that is very closely tied to the microenvironment that it occurs in. Further understanding of these processes may present powerful therapeutic opportunities for disease intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163148     DOI: 10.1016/s0959-437x(00)00153-2

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  35 in total

Review 1.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 2.  Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease.

Authors:  Maria Teresa Rizzo; H Anne Leaver
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

3.  Targeted therapy for renal cell carcinoma: a new treatment paradigm.

Authors:  Thomas E Hutson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

4.  Defective brain development in mice lacking the Hif-1alpha gene in neural cells.

Authors:  Shuhei Tomita; Masaki Ueno; Masami Sakamoto; Yuki Kitahama; Masaaki Ueki; Nobuhiro Maekawa; Haruhiko Sakamoto; Max Gassmann; Ryoichiro Kageyama; Natsuo Ueda; Frank J Gonzalez; Yousuke Takahama
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).

Authors:  Yu-Chen Cai; Yong Zou; Yan-Li Ye; Hong-Yi Sun; Quan-Guan Su; Zhi-Xin Wang; Zhao-Lei Zeng; Li-Jian Xian
Journal:  Invest New Drugs       Date:  2009-12-11       Impact factor: 3.850

Review 6.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

7.  Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein.

Authors:  Li Lei; Steve Mason; Dinggang Liu; Yan Huang; Carolyn Marks; Reed Hickey; Ion S Jovin; Marc Pypaert; Randall S Johnson; Frank J Giordano
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

Review 8.  Does iron have a role in breast cancer?

Authors:  Xi Huang
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

9.  Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.

Authors:  Manoela Tiago; Edson Mendes de Oliveira; Carla Abdo Brohem; Paula Comune Pennacchi; Rafael Duarte Paes; Raquel Brandão Haga; Ana Campa; Silvia Berlanga de Moraes Barros; Keiran S Smalley; Silvya Stuchi Maria-Engler
Journal:  Tissue Eng Part A       Date:  2014-03-25       Impact factor: 3.845

10.  Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.

Authors:  Zhang Lei; Bo Li; Zhuoshun Yang; Haoshu Fang; Gui-Mei Zhang; Zuo-Hua Feng; Bo Huang
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.